A Study to Evaluate Chest Pain Risk Stratification Using HEART Pathway in Community Emergency Departments

Overview

About this study

The objectives of this study are to evaluate utilization of chest pain risk stratification tools in a community hospital emergency department, to evaluate the effect on utilization of inpatient and outpatient resources for chest pain patients when HEART pathway risk stratification is utilized, and to compare the differences in the above outcomes before and after change from 4th to 5th generation Troponin T assays (which occurs in July 2018), in the midst of our study period.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:  

  • We currently have HEART pathway as part of our accepted and ED Practice Committee approved chest pain guideline.  
  • We have educated our entire ED provider staff on utilization of this guideline. 
  • This study will be at retrospective review of the outcomes as providers utilize this approved guideline, so there is no randomization of patients or prospective data collection. 
  • All Emergency department chest pain patients who have troponin testing and HEART pathway score utilization completed will be included.

Exclusion Criteria: 

  • Chest pain patients who do not receive both troponin testing and HEART pathway score completion will be excluded as we do not currently have a way to gather this data in EPIC environment.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Eau Claire, Wis.

Mayo Clinic principal investigator

Alex Beuning, M.D.

Contact us for the latest status

Contact information:

Sierra Kleist

(715)464-8172

Kleist.Sierra@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20471349

Mayo Clinic Footer